Molecular and cellular mechanisms in food anaphylaxis
食物过敏反应的分子和细胞机制
基本信息
- 批准号:10408011
- 负责人:
- 金额:$ 54.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdultAffectAllergicAnaphylaxisAntibioticsAntibodiesAntigensAutomobile DrivingCell physiologyCellsChildDisease modelEczemaEnteralExhibitsFoodFood HypersensitivityGeneral PopulationGenesGerm-FreeGuanine Nucleotide Exchange FactorsIgEImmuneImmunityIncidenceIngestionInterleukin-17Interleukin-4Intestinal permeabilityIntestinesLamina PropriaMediatingMolecularMouse StrainsMusOralOutcomePatientsPhenocopyPredispositionPrevention strategyProductionRegulatory T-LymphocyteRoleSTAT3 geneSamplingSerumSeveritiesSignal TransductionSmall IntestinesT-LymphocyteTestingTh2 CellsTransgenic MiceTryptaseabsorptionantigen challengeantimicrobial peptidecrosslinkcytokinedysbiosisfecal transplantationfood allergengut microbiomeinterleukin-22intestinal epitheliummast cellmicrobiomenovelnovel strategiespassive sensitizationrecurrent infection
项目摘要
Abstract
Food allergy is mediated by antigen crosslinking of IgE antibodies bound to mast cells (MC) and is often
associated with intestinal dysbiosis. IgE sensitization to food is not by itself sufficient to drive food anaphylaxis.
Intestinal MC load, which controls intestinal permeability and systemic antigen absorption, is an important
determinant. The guanine nucleotide exchange factor, DOCK8, is important for STAT3 activation, IL-22, and IL-
17 production. As food allergy and anaphylaxis are cardinal features of DOCK8 deficient patients, DOCK8
deficiency offers an attractive disease model for identifying mechanisms underlying food allergy.
We find elevated serum tryptase levels in DOCK8 deficient patients. Dock8-/- mice exhibit exaggerated IgE-
mediated anaphylaxis to oral, but not i.p. antigen challenge, as well as intestinal MC expansion, which we show
is neither a consequence of a cell intrinsic DOCK8 deficiency within MCs, nor dependent on IgE. Mice with
selective deficiency in DOCK8 in T cells phenocopy Dock8-/- mice, and both exhibit similar intestinal dysbiosis T
cells in the small intestine (SI) lamina propria (LP) of Dock8-/- mice have decreased expression of Il22 and Il17
and increased expression of Il4 and Il13. DOCK8 deficient SI epithelium has decreased expression of
antimicrobial peptide (AMP) genes, but increased numbers of tuft cells and elevated Il25 expression. Treatment
with either sIL-22 or an oral antibiotic cocktail normalizes intestinal MC expansion, suggesting a critical role for
dysbiosis driven by type 17 cytokine deficiency. IL-25 and IL-4 blockade reduce intestinal MC load and passive
oral anaphylaxis in Dock8-/- mice, suggesting a critical role for IL-25, which promotes type 2 cytokine production
by ILC2s and Th2 cells, and for IL-4, which acts on MCs. Importantly, germ free (GF) WT recipients of fecal
microbiota transplantation (FMT) from conventionally raised Dock8-/- mice have significantly greater intestinal
MC load compared to GF WT recipients of FMT from conventionally raised WT controls. Thus, our proposed
studies investigate the mechanisms by which dysbiosis in DOCK8 deficiency may increase intestinal MC load
and thereby promote anaphylaxis are relevant to patients with classic food allergy.
We will test the hypotheses that 1) reduced production of type 17 cytokines due to defective
STAT3 activation in DOCK8 deficiency results in intestinal dysbiosis, 2) dysbiosis causes intestinal tuft
cells to produce IL-25, which drives type 2 cytokine production by ILC2s and Th2 cells, and 3) IL-4, in
turn, drives intestinal MC expansion and activation, thereby promoting anaphylaxis to ingested antigen.
We will make use of transgenic mice and take advantage of our access to DOCK8 deficient patients and
previously well-characterized fecal samples from children with classic food allergy to test our hypotheses.
The proposed studies will delineate how immune mechanisms important for maintaining the intestinal
microbiome regulate intestinal MC expansion and activation, and thereby the severity of food allergy, thus
identifying novel strategies for the prevention and treatment of food allergy.
抽象的
食物过敏是由与肥大细胞(MC)结合的IgE抗体的抗原交联介导的,并且通常是
与肠道营养不良有关。 IgE对食物的敏感本身不足以驱动食物过敏反应。
控制肠道通透性和全身性抗原吸收的肠道MC负载是重要的
决定因素。鸟嘌呤核苷酸交换因子DOCK8对于STAT3激活,IL-22和IL-很重要
17生产。由于食物过敏和过敏反应是Dock8患者的主要特征,Dock8
缺乏症提供了一个有吸引力的疾病模型,用于识别食物过敏的基础机制。
我们发现Dock8缺乏的患者的血清胰蛋白酶水平升高。 dock8 - / - 鼠标表现出夸张的Ige-
介导过敏到口服,但不是i.p.抗原挑战以及肠道MC扩展,我们显示
既不是MC内固有的DOCK8缺乏的结果,也不是依赖IgE的结果。老鼠与
T细胞中DOCK8的选择性缺陷态dock8 - / - 小鼠,并且两者均表现出相似的肠道营养不良T
小肠道(Si)固有层(LP)的细胞dock8 - / - 小鼠的表达降低了IL22和IL17
并增加了IL4和IL13的表达。 Dock8缺乏Si上皮的表达降低
抗菌肽(AMP)基因,但簇状细胞数量增加和IL25表达升高。治疗
用SIL-22或口服抗生素鸡尾酒使肠道MC扩展归一化,这表明对
由17型细胞因子缺乏驱动的营养不良。 IL-25和IL-4阻滞减少肠道MC负载和被动
Dock8 - / - 小鼠中的口服过敏反应,这表明IL-25的关键作用,促进2型细胞因子的产生
由ILC2S和Th2细胞以及对MCS作用的IL-4。重要的是,粪便的无细菌(GF)WT接受者
传统升高的Dock8 - / - 小鼠的微生物群移植(FMT)具有明显更大的肠道
与来自常规升高的WT对照的FMT的GF WT受体相比,MC负载。因此,我们提出了
研究研究了Dock8缺乏症中营养不良的机制可能会增加肠道MC载荷
因此,促进过敏反应与经典食物过敏的患者有关。
我们将检验以下假设,即1)由于缺陷而减少17型细胞因子的产生
Dock8缺乏的STAT3激活导致肠道营养不良,2)营养不良导致肠簇
生产IL-25的细胞,该细胞驱动ILC2和Th2细胞产生2型细胞因子,以及3)IL-4
转弯,驱动肠道MC的膨胀和激活,从而促进过敏症摄入的抗原。
我们将利用转基因小鼠,并利用我们对Dock8不足的患者的机会,
以前有经典食物过敏儿童的特征良好的粪便样品来检验我们的假设。
拟议的研究将描述免疫机制对于维持肠道如何重要
微生物组调节肠道MC的扩张和激活,从而调节食物过敏的严重程度,因此
确定预防和治疗食物过敏的新型策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAIF SALIM GEHA其他文献
RAIF SALIM GEHA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAIF SALIM GEHA', 18)}}的其他基金
Mechanisms of enhanced food allergy by S. aureus skin colonization in Atopic Dermatitis
特应性皮炎中金黄色葡萄球菌皮肤定植增强食物过敏的机制
- 批准号:
10638821 - 财政年份:2023
- 资助金额:
$ 54.8万 - 项目类别:
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
COPG1 纯合突变引起的新型联合免疫缺陷的机制
- 批准号:
10265627 - 财政年份:2020
- 资助金额:
$ 54.8万 - 项目类别:
Molecular and cellular mechanisms in food anaphylaxis
食物过敏反应的分子和细胞机制
- 批准号:
10030396 - 财政年份:2020
- 资助金额:
$ 54.8万 - 项目类别:
Genetic and microbial modifiers of Atopic Dermatitis (AD): Mechanisms of increased AD severity in patients with the R576 polymorphism in IL-4Ra and impact of S aureus skin decolonization on AD
特应性皮炎 (AD) 的遗传和微生物调节剂:IL-4Ra R576 多态性患者 AD 严重程度增加的机制以及金黄色葡萄球菌皮肤去定植对 AD 的影响
- 批准号:
10589788 - 财政年份:2020
- 资助金额:
$ 54.8万 - 项目类别:
Genetic and microbial modifiers of Atopic Dermatitis (AD): Mechanisms of increased AD severity in patients with the R576 polymorphism in IL-4Ra and impact of S aureus skin decolonization on AD
特应性皮炎 (AD) 的遗传和微生物调节剂:IL-4Ra R576 多态性患者 AD 严重程度增加的机制以及金黄色葡萄球菌皮肤去定植对 AD 的影响
- 批准号:
9974923 - 财政年份:2020
- 资助金额:
$ 54.8万 - 项目类别:
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
COPG1 纯合突变引起的新型联合免疫缺陷的机制
- 批准号:
10159668 - 财政年份:2020
- 资助金额:
$ 54.8万 - 项目类别:
Genetic and microbial modifiers of Atopic Dermatitis (AD): Mechanisms of increased AD severity in patients with the R576 polymorphism in IL-4Ra and impact of S aureus skin decolonization on AD
特应性皮炎 (AD) 的遗传和微生物调节剂:IL-4Ra R576 多态性患者 AD 严重程度增加的机制以及金黄色葡萄球菌皮肤去定植对 AD 的影响
- 批准号:
10381494 - 财政年份:2020
- 资助金额:
$ 54.8万 - 项目类别:
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
COPG1 纯合突变引起的新型联合免疫缺陷的机制
- 批准号:
10493663 - 财政年份:2018
- 资助金额:
$ 54.8万 - 项目类别:
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
COPG1 纯合突变引起的新型联合免疫缺陷的机制
- 批准号:
10394995 - 财政年份:2018
- 资助金额:
$ 54.8万 - 项目类别:
Mechanisms of a Novel Combined Immunodeficiency Caused by a Homozygous Mutation in COPG1
COPG1 纯合突变引起的新型联合免疫缺陷的机制
- 批准号:
9912718 - 财政年份:2018
- 资助金额:
$ 54.8万 - 项目类别:
相似国自然基金
翻译后修饰影响卵清蛋白过敏表位的分子机制
- 批准号:32372336
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
湿热地区高校宿舍多物种霉菌共存对学生过敏性鼻炎的健康影响机理研究
- 批准号:52308086
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于社会生态理论的儿童过敏性疾病及其健康影响的多维风险因素识别、动态预警及健康管理策略研究
- 批准号:72374059
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
咳喘停穴位贴敷通过PI3K/AKT/c-Rel调控ILC2s-ICOSL影响Th2免疫应答参与过敏性哮喘的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
空气污染与食物过敏原早期暴露对儿童第二波过敏性疾病的影响研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
TASIS-花生(皮肤内靶向过敏原特异性免疫疗法)贴剂治疗花生过敏的安全性和耐受性
- 批准号:
10551184 - 财政年份:2023
- 资助金额:
$ 54.8万 - 项目类别:
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
- 批准号:
10678307 - 财政年份:2023
- 资助金额:
$ 54.8万 - 项目类别:
Early Life Pulmonary Infection, Microbiome and Trained Innate Immunity
生命早期肺部感染、微生物组和经过训练的先天免疫
- 批准号:
10677304 - 财政年份:2023
- 资助金额:
$ 54.8万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 54.8万 - 项目类别:
Interplay of the T Cell Repertoire Development and Early Life Exposure on Incident Risk of Peanut Allergy
T 细胞库发育和生命早期接触对花生过敏事件风险的相互作用
- 批准号:
10742029 - 财政年份:2023
- 资助金额:
$ 54.8万 - 项目类别: